Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Takahiro Kimura, Taro Igarashi et al.|Japanese Journal of Clinical Oncology|2024Cited by 22
Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter studyFumihiko Urabe, Takafumi Yanagisawa, Wataru Fukuokaya et al.|International Journal of Urology|2024Cited by 20
Bone-Modifying Agents in Patients With High-Risk Metastatic Castration-Sensitive Prostate Cancer Treated With Abiraterone AcetateWataru Fukuokaya, Takahiro Kimura, Keiichiro Mori et al.|JAMA Network Open|2024Cited by 15
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter studyFumihiko Urabe, Takahiro Kimura, Kojiro Tashiro et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 11
Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective studyKatsuki Muramoto, Takahiro Kimura, Fumihiko Urabe et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 7